Core Viewpoint - The stock of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. has experienced abnormal trading fluctuations, with a cumulative closing price increase deviation exceeding 12% over three consecutive trading days, indicating potential market overheating and irrational speculation [1] Group 1: Stock Performance - The company's stock has seen a significant price increase, which is severely deviating from its fundamentals, suggesting a buildup of trading risks [1] - The abnormal trading behavior may lead to a rapid decline in stock price at any moment [1] Group 2: Risks - The company faces multiple delisting risks, including major legal violations, financial delisting, and par value delisting [1] - There are unresolved issues regarding the substantial fund occupation by the controlling shareholder, complete freezing of shares held by the controlling shareholder, and uncertainties surrounding the arbitration results of exclusive agency rights for medical beauty products [1]
*ST苏吴:存在重大违法强制退市、财务类退市、面值退市等多重退市风险
Xin Lang Cai Jing·2025-09-26 09:25